Biphasic pattern of cell turnover characterizes the progression from fatty streaks to ruptured human atherosclerotic plaques

Cardiovascular Research

Volumn 41, Issue 2, 1999, Pages 473-479

  Lutgens, Esther ^a   De Muinck, Ebo D ^a   Kitslaar, Peter J E H M ^a   Tordoir, Jan H M ^a   Wellens, Hein J J ^a   Daemen, Mat J A P ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Apoptosis; Atherosclerosis; Macrophage; Proliferation; Smooth muscle

Indexed keywords

APOPTOSIS; ARTERY INTIMA PROLIFERATION; ARTERY WALL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CELL COUNT; DISEASE CLASSIFICATION; DISEASE COURSE; DNA SYNTHESIS; FOAM CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; PHENOTYPE; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; APOPTOSIS; ARTERIOSCLEROSIS; CELL DIVISION; DNA; FEMALE; FOAM CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; TIME FACTORS; TUNICA INTIMA;

EID: 0033019113     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(98)00311-3     Document Type: Article

References (37)

1. Rekhter M.D., Gordon D. Active proliferation of different cell types, including lymphocytes, in human atherosclerotic plaques. Am J Pathol. 147:1995;668-677.
2. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
3. Han D.K.M., Haudenschild C.C.H., Hong M.K.et al. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am J Pathol. 147:1995;267-277.
4. Isner J.M., Kearney M., Bortman S., Passeri J. Apoptosis in human atherosclerosis and restenosis. Circulation. 91:1995;2703-2711.
5. Brandl R., Richter T., Haug K.et al. Topographic analysis of proliferative activity in carotid endarterectomy specimens by immunocytochemical detection of the cell cycle-related antigen Ki-67. Circulation. 96:1997;3360-3368.
6. Kockx M.M., de Meyer G.R.Y., Muhring J.et al. Apoptosis and related proteins in different stages of human atherosclerotic plaques. Circulation. 97:1998;2307-2315.
7. Orekhov A.N., Andreeva E.R., Mikhailova I.A., Gordon D. Cell proliferation in normal and atherosclerotic human aorta: proliferative splash in lipid-rich lesions. Arteriosclerosis. 139:1998;41-48.
8. Lee R.T., Libby P. The unstable atheroma. Arterioscler Thromb Vasc Biol. 17:1997;1859-1866.
9. Davies M.J., Woolf N., Rowles P., Richardson P.D. Lipid and cellular constituents of unstable human aortic plaques. Basic Res Cardiol. 89(suppl 1):1994;33-39.
10. O'Brien E.R., Alpers C.E., Stewart D.K.et al. Proliferation in primary and restenotic coronary atherectomy tissue. Implications for antiproliferative therapy. Circ Res. 73:1993;223-231.
11. Gordon D., Reidy M.A., Benditt E.P., Schwartz S.M. Cell proliferation in human coronary arteries. Proc Natl Acad Sci USA. 87:1990;4600-4604.
12. Geng Y.J., Libby P. Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme. Am J Pathol. 147:1995;251-266.
13. Bjorkerud S., Bjorkerud B. Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. Am J Pathol. 149:1996;367-380.
14. Crisby M., Kallin B., Thyberg J.et al. Cell death in human atherosclerotic plaques involves both oncosis and apoptosis. Atherosclerosis. 130:1997;17-27.
15. Waller B.F., Johnson D.E., Schnitt S.J.et al. Histologic analysis of directional coronary atherectomy samples. A review of findings and their clinical relevance. Am J Cardiol. 72:1993;80E-87E.
16. Stary H.C., Chandler A.B., Dinsmore R.E.et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis American Heart Association. Arterioscler Thromb Vasc Biol. 15:1995;1512-1531.
17. Gerdes J., Li L., Schlueter C.et al. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol. 138:1991;867-873.
18. McCormick D., Chong H., Hobbs C., Datta C., Hall P.A. Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB1. Histopathology. 22:1993;355-360.
19. Wijsman J.H., Jonker R.R., Keijzer R.et al. A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. J Histochem Cytochem. 41:1993;7-12.
20. Majno G., Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol. 146:1995;3-15.
21. Schwartz S.M., Bennett M.R. Death by any other name. Am J Pathol. 147:1995;229-234.
22. Kockx M.M., Muhring J., Knaapen M.W.M., de Meyer G.R.Y. RNA synthesis and splicing interferes with DNA in situ end labeling techniques used to detect apoptosis. Am J Pathol. 152:1998;885-888.
23. Gordon D., Schwartz S.M. Cell proliferation in human atherosclerosis. Trends Cardiovasc Med. 1:1991;24-28.
24. Orekhov A.N., Kosykh V.A., Repin V.S., Smirnov V.N. Cell proliferation in normal and atherosclerotic aorta. II. Autoradiographic observation on deoxyribonucleic acid synthesis in primary cell culture. Lab Invest. 48:1983;749-754.
25. Rosenfeld M.E., Ross R. Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis. 10:1990;680-687.
26. *3 Leiden transgenic mice: from proliferative to atheromatous stage. Circulation 1999:in press.
27. Fischer-Dzoga K. Cellular proliferation, cellular death and atherosclerosis. Artery. 5:1979;222-236.
28. Bjorkerud B., Bjorkerud S. Contrary effects of lightly and strongly oxidized LDL with potent promotion of growth versus apoptosis on arterial smooth muscle cells, macrophages and fibroblasts. Arterioscler Thromb Vasc Biol. 16:1996;416-424.
29. Hegyi L., Skepper J.N., Cary N.R.B., Mitchinson M.J. Foam cell apoptosis and the development of the lipid core of human atherosclerosis. J Pathol. 180:1996;423-429.
30. Kockx M.M., Muhring J., Bortier H., de Meyer G.R., Jacob W. Biotin- or digoxigenin-conjugated nucleotides bind to matrix vesicles in atherosclerotic plaques. Am J Pathol. 148:1996;1771-1777.
31. Falk E. Why do plaques rupture? Circulation. 86:1992;III30-III42.
32. Reid V.C., Mitchinson M.J., Skepper J.N. Cytotoxicity of oxidized low-density lipoprotein to mouse peritoneal macrophages: an ultrastructural study. J Pathol. 171:1993;321-328.
33. Reid V.C., Mitchinson M.J. Toxicity of oxidized low density lipoprotein towards mouse peritoneal macrophages in vitro. Atherosclerosis. 98:1993;17-24.
34. Geng Y.J., Henderson L.E., Levesque E.B., Muszynski M., Libby P. Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 17:1997;2200-2208.
35. Jovinge S., Crisby M., Thyberg J., Nilsson J. DNA-fragmentation and ultrastructural changes of degenerating cells in atherosclerotic lesions and smooth muscle cells exposed to oxidized LDL in vitro. Arterioscler Thromb Vasc Biol. 17:1997;2225-2231.
36. Weissberg P.L., Clesham G.J., Bennett M.R. Is vascular smooth muscle cell proliferation beneficial? Lancet. 347:1996;305-307.
37. Flugelman M.Y., Virmani R., Correa R. Smooth muscle cell abundance and fibroblast growth factors in coronary lesions of patients with nonfatal unstable angina. A clue to the mechanism of transformation from the stable to the unstable clinical state. Circulation. 88:1993;2493-2500.